Literature DB >> 8314306

Changes in perfusion of mouse tumours after photodynamic therapy.

I P van Geel1, H Oppelaar, Y G Oussoren, F A Stewart.   

Abstract

The influence of photodynamic therapy (PDT) on vascular perfusion was investigated in 2 s.c. mouse tumours, a radiation-induced fibrosarcoma (RIF I) and a squamous-cell carcinoma (SCCVII). The 86Rb extraction technique was used to measure changes in perfusion relative to cardiac output at various intervals after interstitial PDT. Control groups showed that vascular perfusion in the RIF I tumours decreased with increasing tumour size. For both tumours, of constant size, vascular perfusion decreased to less than 10% of control values within 5 min after high PDT doses. Significant decreases in vascular perfusion were also seen after lower, sub-curative doses. Thereafter there was slow recovery towards control levels. Photofrin given at shorter intervals before illumination generally resulted in even larger decreases in tumour perfusion, and slower recovery. Comparison of tumour perfusion measurements after PDT with tumour response revealed an inverse correlation with tumour growth delay both for the RIF I and for the SCCVII tumours. PDT with sub-curative light doses appears to decrease vascular perfusion in the RIF I and SCCVII for a period of at least 24 hr. The most severe reductions in tumour blood flow were associated with the longest regrowth delays, indicating a major role of vascular damage in tumour response to PDT.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8314306     DOI: 10.1002/ijc.2910560214

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Implicit and explicit dosimetry in photodynamic therapy: a New paradigm.

Authors:  B C Wilson; M S Patterson; L Lilge
Journal:  Lasers Med Sci       Date:  1997-10       Impact factor: 3.161

2.  Aminolevulinic acid-photodynamic therapy combined with topically applied vascular disrupting agent vadimezan leads to enhanced antitumor responses.

Authors:  Allison Marrero; Theresa Becker; Ulas Sunar; Janet Morgan; David Bellnier
Journal:  Photochem Photobiol       Date:  2011-06-13       Impact factor: 3.421

Review 3.  Current concepts in gastrointestinal photodynamic therapy.

Authors:  J Webber; M Herman; D Kessel; D Fromm
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

4.  Influence of a haematoporphyrin derivative on the protoporphyrin IX synthesis and photodynamic effect after 5-aminolaevulinic acid sensitization in human colon carcinoma cells.

Authors:  H Messmann; M Geisler; U Gross; C Abels; R M Szeimies; P Steinbach; R Knüchel; M Doss; J Schölmerich; A Holstege
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours.

Authors:  M Korbelik; J Sun; H Zeng
Journal:  Br J Cancer       Date:  2003-03-10       Impact factor: 7.640

6.  Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy.

Authors:  M Korbelik; C S Parkins; H Shibuya; I Cecic; M R Stratford; D J Chaplin
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

7.  Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate.

Authors:  T M Sitnik; J A Hampton; B W Henderson
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

8.  Intraperitoneal photodynamic therapy of the rat CC531 adenocarcinoma.

Authors:  R B Veenhuizen; J P Marijnissen; P Kenemans; M C Ruevekamp-Helmers; L W 't Mannetje; T J Helmerhorst; F A Stewart
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

9.  Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy.

Authors:  I P van Geel; H Oppelaar; P F Rijken; H J Bernsen; N E Hagemeier; A J van der Kogel; R J Hodgkiss; F A Stewart
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

10.  Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C.

Authors:  I P van Geel; H Oppelaar; Y G Oussoren; J J Schuitmaker; F A Stewart
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.